CLINICAL TRIALS PROFILE FOR ROTARIX
✉ Email this page to a colleague
All Clinical Trials for ROTARIX
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00370318 ↗ | Prophylactic Antipyretic Treatment in Children Receiving Pneumococcal Conjugate and Standard Infant Vaccines | Completed | GlaxoSmithKline | Phase 3 | 2006-09-01 | The purpose of this trial is to assess if the rate of febrile reactions following the co-administration of pneumococcal conjugate vaccines with standard infant vaccines is lowered when paracetamol is given prophylactically. |
NCT01259765 ↗ | Llama Antibody, Rotavirus Diarrhoea, Children | Completed | Unilever Nederland Holdings | Phase 2 | 2006-01-01 | The investigators hypothesize that : oral administration of VHH batch 203027 will be - safe and tolerable for healthy Bangladeshi humans of all age groups (Part I) - effective in reducing severity of diarrhoea in children with proven rotavirus infection (Part II). This entry only covers Part II. |
NCT01259765 ↗ | Llama Antibody, Rotavirus Diarrhoea, Children | Completed | International Centre for Diarrhoeal Disease Research, Bangladesh | Phase 2 | 2006-01-01 | The investigators hypothesize that : oral administration of VHH batch 203027 will be - safe and tolerable for healthy Bangladeshi humans of all age groups (Part I) - effective in reducing severity of diarrhoea in children with proven rotavirus infection (Part II). This entry only covers Part II. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for ROTARIX
Condition Name
Clinical Trial Locations for ROTARIX
Trials by Country
Clinical Trial Progress for ROTARIX
Clinical Trial Phase
Clinical Trial Sponsors for ROTARIX
Sponsor Name